Gao Xiao-Lei, Zhang Mei, Tang Ya-Ling, Liang Xin-Hua
State Key Laboratory of Oral Diseases.
Department of Oral and Maxillofacial Surgery.
Onco Targets Ther. 2017 Oct 27;10:5219-5228. doi: 10.2147/OTT.S140854. eCollection 2017.
More recently, disease metastasis and relapse in many cancer patients several years (even some decades) after surgical remission are regarded as tumor dormancy. However, the knowledge of this phenomenon is cripplingly limited. Substantial quantities of reviews have summarized three main potential models that can be put forth to explain such process, including angiogenic dormancy, immunologic dormancy, and cellular dormancy. In this review, newly uncovered mechanisms governing cancer cell dormancy are discussed, with an emphasis on the cross talk between dormant cancer cells and their microenvironments. In addition, potential mechanisms of reactivation of these dormant cells in certain anatomic sites including lymph nodes and bone marrow are discussed. Molecular mechanism of cellular dormancy in head and neck cancer is also involved.
最近,许多癌症患者在手术缓解数年(甚至数十年)后出现的疾病转移和复发被视为肿瘤休眠。然而,对这一现象的了解极其有限。大量综述总结了三种主要的潜在模型来解释这一过程,包括血管生成性休眠、免疫性休眠和细胞休眠。在本综述中,我们讨论了新发现的控制癌细胞休眠的机制,重点是休眠癌细胞与其微环境之间的相互作用。此外,还讨论了这些休眠细胞在某些解剖部位(包括淋巴结和骨髓)重新激活的潜在机制。头颈部癌细胞休眠的分子机制也有所涉及。